Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000357174

Medchemexpress LLC Mindeudesivir hydrobromide | 2779498-79-0 | 98.2% | C24H31DBrN5O7 | 25 MG
SDP

Catalog No. 5000357174
Encompass_Preferred

Mindeudesivir hydrobromide (VV116) is a deuterated version of Remdesivir, a highly orally active nucleoside antiviral agent against SARS-CoV-2 and respiratory syncytial virus (RSV). It maintains the antiviral activity of Remdesivir against COVID-19 and is noted as the first domestically produced deuterium targeting COVID-19. Deuteration can affect the pharmacokinetic and metabolic profiles of drugs, potentially offering several advantages.

  • Used as a tracer or internal standard for quantitative analysis.
  • Extends in vivo half-life and improves oral bioavailability.
  • Improves metabolic characteristics and drug safety.
  • Preserves therapeutic properties.
  • Inhibits RSV replication in A549 cells.
  • Shows strong antiviral activity against RSV in mice.
  • Exhibits favorable pharmacokinetic properties and good safety profile.

Catalog No. 50-003-57174 Supplier Medchemexpress LLC Supplier No. 25MGHY145119AS
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Mindeudesivir hydrobromide (VV116) is a deuterated version of Remdesivir, a highly orally active nucleoside antiviral agent against SARS-CoV-2 and respiratory syncytial virus (RSV). It maintains the antiviral activity of Remdesivir against COVID-19 and is noted as the first domestically produced deuterium targeting COVID-19. Deuteration can affect the pharmacokinetic and metabolic profiles of drugs, potentially offering several advantages.

  • Used as a tracer or internal standard for quantitative analysis.
  • Extends in vivo half-life and improves oral bioavailability.
  • Improves metabolic characteristics and drug safety.
  • Preserves therapeutic properties.
  • Inhibits RSV replication in A549 cells.
  • Shows strong antiviral activity against RSV in mice.
  • Exhibits favorable pharmacokinetic properties and good safety profile.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.